Galderma Group AG
GALD
Clasificación en acciones
#457
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Precio por acción
$224.81
Capitalización bursátil
$52.42B
Cambio (1 día)
6.31%
Cambio (1 año)
31.28%
País
CH
Comercio Galderma Group AG (GALD)
Categoría
Healthcare
Ganancias de Galderma Group AG (GALD)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Galderma Group AG, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Galderma Group AG desde 2021 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2025 | $638.00M | 86.91% |
| 2024 | $341.33M | 3,003.04% |
| 2023 | $11.00M | -120.52% |
| 2022 | $-53.59M | -32.74% |
| 2021 | $-79.68M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| $1.76B | - |
IN
|
|
| - | - |
CN
|
